Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

756
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
756
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

335
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

490
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
490
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generative artificial intelligence adoption and use in teaching and training healthcare professionals in higher education in the United States: a cross-sectional study.

BMC medical education·2026
Same author

Healthcare Providers' Perspectives on Generative Artificial Intelligence (GenAI) Adoption, Adaptation, Assimilation, and Use in the United States.

Healthcare (Basel, Switzerland)·2026
Same author

Transforming Public Health Practice with Artificial Intelligence: A Framework-Driven Approach.

Healthcare (Basel, Switzerland)·2026
Same author

ETHICS of AI Adoption and Deployment in Health Care: Progress, Challenges, and Next Steps.

JMIR AI·2025
Same author

Global Adoption, Promotion, Impact, and Deployment of AI in Patient Care, Health Care Delivery, Management, and Health Care Systems Leadership: Cross-Sectional Survey.

Journal of medical Internet research·2025
Same author

Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection.

PLoS neglected tropical diseases·2025

Related Experiment Video

Updated: Mar 30, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K

Diagnosing and treating hepatic encephalopathy.

Olivia Tiberi1, Joshua M Tognarelli2, Nicola A Cook3

  • 1Biomedical Sciences Graduate.

British Journal of Hospital Medicine (London, England : 2005)
|November 10, 2015
PubMed
Summary

This article reviews diagnostic and management strategies for hepatic encephalopathy, a complex liver condition. It also examines the effects of minimal hepatic encephalopathy and ethical considerations in patient treatment.

More Related Videos

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

1.1K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.1K

Related Experiment Videos

Last Updated: Mar 30, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

1.1K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

12.1K

Area of Science:

  • Hepatology
  • Neurology
  • Medical Ethics

Background:

  • Hepatic encephalopathy (HE) is a multifactorial neuropsychiatric complication of liver dysfunction.
  • The spectrum of HE ranges from overt symptoms to subtle cognitive deficits, known as minimal hepatic encephalopathy (MHE).
  • Accurate diagnosis and effective management of HE are crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the diagnostic efficacy of current methods for hepatic encephalopathy.
  • To assess the effectiveness of various therapeutic strategies for managing hepatic encephalopathy.
  • To discuss the impact of minimal hepatic encephalopathy on patients and the ethical dimensions of its treatment.

Main Methods:

  • Literature review of diagnostic tools for HE, including psychometric tests and neuroimaging.
  • Analysis of clinical trial data and guidelines on pharmacological and non-pharmacological interventions for HE.
  • Ethical framework analysis concerning MHE diagnosis and treatment.

Main Results:

  • Current diagnostic methods show variable efficacy, with a need for standardized approaches.
  • Management strategies offer symptomatic relief, but long-term efficacy and optimal treatment protocols require further investigation.
  • MHE significantly impacts patients' quality of life and daily functioning, raising ethical questions about screening and intervention.

Conclusions:

  • Hepatic encephalopathy diagnosis and management require a comprehensive, multidisciplinary approach.
  • Further research is needed to refine diagnostic accuracy and optimize treatment efficacy for all stages of HE.
  • Addressing the impact and ethical considerations of MHE is essential for holistic patient care.